ACLARION INC
(NASDAQ: ACON)
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
0.292
+0.009
(+3.18%)
Range
0.283 - 0.300
(6.01%)
Open
0.300
Previous Close
0.283
Bid Price
0.590
Bid Volume
14
Ask Price
0.627
Ask Volume
10
Volume
340,906
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis